These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 22399488)
1. Small-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growth. Tan Z; Wortman M; Dillehay KL; Seibel WL; Evelyn CR; Smith SJ; Malkas LH; Zheng Y; Lu S; Dong Z Mol Pharmacol; 2012 Jun; 81(6):811-9. PubMed ID: 22399488 [TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of a novel small molecule targeting PCNA chromatin association in prostate cancer. Dillehay KL; Lu S; Dong Z Mol Cancer Ther; 2014 Dec; 13(12):2817-26. PubMed ID: 25253786 [TBL] [Abstract][Full Text] [Related]
3. Target validation and structure-activity analysis of a series of novel PCNA inhibitors. Dillehay KL; Seibel WL; Zhao D; Lu S; Dong Z Pharmacol Res Perspect; 2015 Mar; 3(2):e00115. PubMed ID: 25729582 [TBL] [Abstract][Full Text] [Related]
4. Additive effects of a small molecular PCNA inhibitor PCNA-I1S and DNA damaging agents on growth inhibition and DNA damage in prostate and lung cancer cells. Lu S; Dong Z PLoS One; 2019; 14(10):e0223894. PubMed ID: 31600334 [TBL] [Abstract][Full Text] [Related]
6. Identification of small molecule proliferating cell nuclear antigen (PCNA) inhibitor that disrupts interactions with PIP-box proteins and inhibits DNA replication. Punchihewa C; Inoue A; Hishiki A; Fujikawa Y; Connelly M; Evison B; Shao Y; Heath R; Kuraoka I; Rodrigues P; Hashimoto H; Kawanishi M; Sato M; Yagi T; Fujii N J Biol Chem; 2012 Apr; 287(17):14289-300. PubMed ID: 22383522 [TBL] [Abstract][Full Text] [Related]
7. Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation. Cardano M; Tribioli C; Prosperi E Curr Cancer Drug Targets; 2020; 20(4):240-252. PubMed ID: 31951183 [TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen (PCNA) may function as a double homotrimer complex in the mammalian cell. Naryzhny SN; Zhao H; Lee H J Biol Chem; 2005 Apr; 280(14):13888-94. PubMed ID: 15805117 [TBL] [Abstract][Full Text] [Related]
9. The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA. Gu L; Lingeman R; Yakushijin F; Sun E; Cui Q; Chao J; Hu W; Li H; Hickey RJ; Stark JM; Yuan YC; Chen Y; Vonderfecht SL; Synold TW; Shi Y; Reckamp KL; Horne D; Malkas LH Clin Cancer Res; 2018 Dec; 24(23):6053-6065. PubMed ID: 29967249 [TBL] [Abstract][Full Text] [Related]
10. Alternative replication factor C protein, Elg1, maintains chromosome stability by regulating PCNA levels on chromatin. Shiomi Y; Nishitani H Genes Cells; 2013 Nov; 18(11):946-59. PubMed ID: 23937667 [TBL] [Abstract][Full Text] [Related]
11. PCNA is recruited to irradiated chromatin in late S-phase and is most pronounced in G2 phase of the cell cycle. Bártová E; Suchánková J; Legartová S; Malyšková B; Hornáček M; Skalníková M; Mašata M; Raška I; Kozubek S Protoplasma; 2017 Sep; 254(5):2035-2043. PubMed ID: 28168519 [TBL] [Abstract][Full Text] [Related]
12. Histone H3K79 demethylation by KDM2B facilitates proper DNA replication through PCNA dissociation from chromatin. Kang JY; Park JW; Hahm JY; Jung H; Seo SB Cell Prolif; 2020 Nov; 53(11):e12920. PubMed ID: 33029857 [TBL] [Abstract][Full Text] [Related]
13. The γ-tubulin meshwork assists in the recruitment of PCNA to chromatin in mammalian cells. Corvaisier M; Zhou J; Malycheva D; Cornella N; Chioureas D; Gustafsson NMS; Rosselló CA; Ayora S; Li T; Ekström-Holka K; Jirström K; Lindström L; Alvarado-Kristensson M Commun Biol; 2021 Jun; 4(1):767. PubMed ID: 34158617 [TBL] [Abstract][Full Text] [Related]
14. Interaction of proliferation cell nuclear antigen (PCNA) with c-Abl in cell proliferation and response to DNA damages in breast cancer. Zhao H; Ho PC; Lo YH; Espejo A; Bedford MT; Hung MC; Wang SC PLoS One; 2012; 7(1):e29416. PubMed ID: 22238610 [TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen associates with histone deacetylase activity, integrating DNA replication and chromatin modification. Milutinovic S; Zhuang Q; Szyf M J Biol Chem; 2002 Jun; 277(23):20974-8. PubMed ID: 11929879 [TBL] [Abstract][Full Text] [Related]
16. A site-selective, irreversible inhibitor of the DNA replication auxiliary factor proliferating cell nuclear antigen (PCNA). Evison BJ; Actis ML; Wu SZ; Shao Y; Heath RJ; Yang L; Fujii N Bioorg Med Chem; 2014 Nov; 22(22):6333-43. PubMed ID: 25438756 [TBL] [Abstract][Full Text] [Related]
17. Effects of cycloheximide on chromatin-bound and -unbound PCNA in HeLa cells. Sasaki K; Kurose A; Uesugi N; Kato A Oncology; 1995; 52(5):419-21. PubMed ID: 7637960 [TBL] [Abstract][Full Text] [Related]
19. Small molecule targeting of transcription-replication conflict for selective chemotherapy. Gu L; Li M; Li CM; Haratipour P; Lingeman R; Jossart J; Gutova M; Flores L; Hyde C; Kenjić N; Li H; Chung V; Li H; Lomenick B; Von Hoff DD; Synold TW; Aboody KS; Liu Y; Horne D; Hickey RJ; Perry JJP; Malkas LH Cell Chem Biol; 2023 Oct; 30(10):1235-1247.e6. PubMed ID: 37531956 [TBL] [Abstract][Full Text] [Related]
20. Dynamic changes in subnuclear NP95 location during the cell cycle and its spatial relationship with DNA replication foci. Miura M; Watanabe H; Sasaki T; Tatsumi K; Muto M Exp Cell Res; 2001 Feb; 263(2):202-8. PubMed ID: 11161719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]